Drugs that contain Dimethyl Fumarate

1. Drug name - TECFIDERA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8399514 BIOGEN INC Treatment for multiple sclerosis Feb, 2028

(5 years from now)

US10391160 BIOGEN INC Dimethyl fumarate and vaccination regimens Mar, 2035

(12 years from now)

US10994003 BIOGEN INC Dimethyl fumarate and vaccination regimens Mar, 2035

(12 years from now)

US10555993 BIOGEN INC Dimethyl fumarate and vaccination regimens Mar, 2035

(12 years from now)

US11007167 BIOGEN INC Methods of treating multiple sclerosis Nov, 2035

(13 years from now)

US10959972 BIOGEN INC Methods of treating multiple sclerosis Nov, 2035

(13 years from now)

US11129806 BIOGEN INC Methods of treating multiple sclerosis Nov, 2035

(13 years from now)

US11007166 BIOGEN INC Methods of treating multiple sclerosis Nov, 2035

(13 years from now)

Treatment: Method of treating multiple sclerosis; Method of treating relapsing forms of multiple sclerosis before and after administering an inactive vaccine

Dosage: CAPSULE, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
120MG CAPSULE, DELAYED RELEASE;ORAL Prescription
240MG CAPSULE, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.